+1,660.3%
PLTR vs MRNA
+98.6%
+1,561.8%
-84.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.8% | +5.4% | -4.6% | +0.1% |
| 7D | -4.1% | -1.1% | -3.0% | -4.0% |
| 30D | -2.2% | +126.1% | -128.3% | -22.9% |
| 3M | +27.6% | +190.0% | -162.4% | -6.5% |
| 6M | +10.3% | +157.2% | -146.9% | -17.3% |
| YTD | -5.9% | +388.2% | -394.1% | -42.0% |
| 1Y | +1.7% | +467.0% | -465.3% | -41.0% |
| 3Y | +959.1% | +36.1% | +923.0% | +740.6% |
| 5Y | +536.3% | -68.0% | +604.3% | +604.2% |
| All | +1,660.3% | +98.6% | +1,561.8% | +1,000.7% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling